The pharmaceutical industry is evolving. Unprecedented challenges in the industry are raising concerns about innovations that increase R&D, administrative and sales cost. Some of the challenges include:
- Expiring patents
- Increase in competition by generic companies
- Slower sales growth rates
- Decrease in the number of innovative drugs under development
- Tighter regulatory reviews and standards
These factors are causing pharmaceutical companies to change their strategies, however, they must do so in a way that combines tactical short-term actions with long-term initiatives that tie to a larger, strategic vision.
We are experts in creating agents of change, cultures of innovation and leaders who thrive when confronted with ambiguity. We have created unique development solutions to suit the needs of our pharmaceutical client portfolio, which includes Celgene, Teva and Skryker.